Bleeding complications in immune thrombocytopenia

Area of Science:

• Hematology
• Immunology
• Clinical Medicine

Background:

• Immune thrombocytopenia (ITP) presents with a spectrum of bleeding, from mild bruising to life-threatening intracranial hemorrhage (ICH).
• Severe bleeding in ITP is typically associated with very low platelet counts (<10 × 10(9)/L).
• Estimates suggest ICH occurs in approximately 0.5% of children and 1.5% of adults with ITP.

Purpose of the Study:

• To review the bleeding manifestations in immune thrombocytopenia (ITP).
• To discuss the challenges in assessing severe bleeding in ITP.
• To outline guiding principles for managing ITP based on bleeding risk.

Main Methods:

• Review of clinical studies, ITP registries, and administrative databases.
• Analysis of bleeding manifestations and their correlation with platelet counts.
• Synthesis of management principles based on bleeding risk.

Main Results:

• Severe bleeding, including ICH, is uncommon at platelet counts >30 × 10(9)/L.
• Accurate estimation of severe non-ICH bleeding is challenging due to lack of standardized definitions and assessment tools.
• Observation alone is a safe management strategy for many ITP patients, particularly children.

Conclusions:

• Treatment decisions in ITP should be guided by the presence and severity of bleeding, not solely by platelet count.
• For chronic ITP, the least toxic treatments at the lowest effective doses are recommended.
• Emergency management of severe bleeding may require combination therapy, and early aggressive treatment can lead to durable responses.